BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30348662)

  • 1. FK506 Resistance of
    Tanabe K; Bonus M; Tomiyama S; Miyoshi K; Nagi M; Niimi K; Chindamporn A; Gohlke H; Schmitt L; Cannon RD; Niimi M; Lamping E
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
    Niimi M; Niimi K; Tanabe K; Cannon RD; Lamping E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0174821. PubMed ID: 34780272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.
    Egner R; Rosenthal FE; Kralli A; Sanglard D; Kuchler K
    Mol Biol Cell; 1998 Feb; 9(2):523-43. PubMed ID: 9450972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1.
    Madani G; Lamping E; Cannon RD
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
    Kalkandelen KT; Doluca Dereli M
    Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals.
    Prasad R; De Wergifosse P; Goffeau A; Balzi E
    Curr Genet; 1995 Mar; 27(4):320-9. PubMed ID: 7614555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
    Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
    Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Calabrese D; Bille J; Sanglard D
    Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transmission interface of the Saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in drug resistance.
    Downes MT; Mehla J; Ananthaswamy N; Wakschlag A; Lamonde M; Dine E; Ambudkar SV; Golin J
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1025-34. PubMed ID: 23254431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Efflux Capability and Substrate Specificity of Aspergillus fumigatus PDR5-like ABC Transporters Expressed in Saccharomyces cerevisiae.
    Esquivel BD; Rybak JM; Barker KS; Fortwendel JR; Rogers PD; White TC
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.